Join Redox Medicine 2024
It is a great pleasure to announce the 26th International Conference on Redox Medicine 2024, which will be held on June 27-28, at Fondation Biermans-Lapôtre, Paris, France.
Speakers of Redox Medicine 2024
Keynote Day 1 Small Molecule Electrophiles: Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development Bruce Freeman, University of Pittsburgh, USA |
Keynote Day 2 Redox Interactome in Physiopathology Miria Ricchetti, Institut Pasteur, France |
Antioxidants Stimulate Blood Flow in Tumors Martin O. Bergo, Karolinska Institutet, Sweden |
Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling Mario D. Cordero, Universidad Pablo de Olavide, Spain |
Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia Christel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France |
Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner Zaher El Beck, Karolinska Institutet and Uppsala University, Sweden |
Metabolic Regulation by Redox Signaling in the Heart Tamara Tomin, TU Wien, Austria |
The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism Nexus Laurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France |
NADH: The Redox Sensor in Aging-Related Disorders Roberta Rizzo, Università degli Studi di Ferrara, Italy |
Redox Implications of Supplementary Oxygen during Major Abdominal Surgery Andrew Cumpstey, University of Southampton, United Kingdom |
New Insights into the Impact of Oxidative Stress in Hypertensive Diseases of Pregnancy Daniel Vaiman, DR1 INSERM, Institut Cochin, France |
Redox Medicine 2024: Biomarkers Carole Nicco, President of Redox Medicine Society |
Identifying Oxidized Lipids in Neurodegenerative Diseases Sayuri Miyamoto, University of São Paulo, Brazil |
Exploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to Severity Jumana Saleh, Sultan Qaboos University, Oman |
Redox, Radiotherapy and Biomarkers Radia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France |
Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases Jeffrey A. Johnson, University of Wisconsin, USA |
Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next-Generation Therapeutics Govindasamy Mugesh, Indian Institute of Science, India |
Drug repurposing on Alzheimer's Disease & NRF2 Modulation George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus |
Pharma’s Search for Redox-Modulating Therapeutics Duncan Emerton, Vice-President of Citeline, United Kingdom |
How to Develop a Drug – From Preclinical to Clinical Antonio Vila-Coro, IQVIA, Spain |
Artificial Intelligence in NeuroInflammation, Biomarkers and Redox Medicine Stéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris |
Artificial Intelligence & Algorithms: Applications in Redox Medicine & Radiology Maxime Barat, Université Paris Cité, Hôpital Cochin, France |
Redox Medicine 2024 Attendees
Citeline (Sponsor) |
Pusan National University |
Last updated on 12/04/2024